Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
Pavlo Petakh(Kyiv School of Economics), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Valentyn Oksenych(University of Bergen), Iryna Kamyshna(I.Horbachevsky Ternopil National Medical University), Denis E. Kainov(Norwegian University of Science and Technology)
Cited by 24
Related Papers
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
|Cell Reports Medicine|2021|219
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64